504538914
`
`09/08/201 7
`
`PATENT ASSIGNMENT COVER SHEET
`
`Electronic Version v1.1
`
`Stylesheet Version v1.2
`
`SUBMISSION TYPE:
`
`NEW ASSIGNMENT
`
`NATURE OF CONVEYANCE:
`
`ASSIGNMENT
`
`EPAS ID: PAT4585621
`
`CONVEYING PARTY DATA
`
`
`
`Name Execution Date
`
`
`
`ALLERGAN, INC.
`
`09/08/2017
`
`RECEIVING PARTY DATA
`
`m SAINT REGIS MOHAWK TRIBE
`
`Street Address:
`412 STATE ROUTE 37
`
`
`City:
`AKWESASNE
`
`State/Country:
`NEW YORK
`Postal Code:
`13655
`
`
`PROPERTY NUMBERS Total: 6
`
` Phone:
`
`
`
`Patent Number: 8633162
`
`
`
`Patent Number:
`
`Patent Number:
`
`Patent Number:
`
`Patent Number:
`
`8642556
`
`8648048
`
`8685930
`
`9248191
`
`CORRESPONDENCE DATA
`
`(714)246—4249
`Fax Number:
`Correspondence will be sent to the e-mail address first; if that is unsuccessful, it will be sent
`using a fax number, if provided; if that is unsuccessful, it will be sent via US Mail.
`714—246—4500
`
`Email:
`Correspondent Name:
`Address Line 1:
`Address Line 4:
`
`patents_ip@allergan.com
`ALLERGAN, INC.
`2525 DUPONT DRIVE, T2-7H
`IRVINE, CALIFORNIA 92612-1599
`
`ATTORNEY DOCKET NUMBER:
`17618
`
`
`NAME OF SUBMITTER:
`LAURA L. WINE
`
`
`SIGNATURE:
`
`DATE SIGNED:
`
`/Laura L. Wine/
`
`09/08/2017
`
`Total Attachments: 6
`
`504538914
`
`PATENT
`
`REEL: 043532 FRAME: D422
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`SRMT 2103 - Pg. 1
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`source=Short form-Patent Assignment - Signed#page1.tif
`source=Short form-Patent Assignment - Signed#page2.tit
`source=Sh0rt form—Patent Assignment — Signed#page3.tif
`source=Short form—Patent Assignment — Signed#page4.tif
`source=Short form—Patent Assignment — Signed#page5.tif
`
`source=Short form-Patent Assignment - Signed#page6.tif
`
`PATENT
`REEL: 043532 FRAME: D423
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 2
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`bXflfi’iHflN VERSKAY
`
`SEGRT FCSRM yATEN'E‘ ASSEGNMENT
`
`This Patent Aasigamem{111555“‘Assig5515115111"3 is mafia 53 {15‘ $65556555E155 5‘5, 2131’?
`15551911 1121113, 5115 “53115525555 1.355515”). by 1555521 3555115151555 5351155213551, 15555..
`21 35515555155555 05555555515555:
`{“Assigmr"). and 85111151 R5355:
`1515521555115 T511551.
`11 fefiemiiymwgnimd 55955155555555 1115515115.
`59555555155151 "1:11:15: {“A5signee”}.
`
`WHEREAS. Agsignm 53151553 1112: 5155555555 25553 515515.555 555551155155105555 955 £05551 £11
`.555555555555555 A {1155: “91511511193
`
`515515555 50
`5511151
`05555115535
`5555151555.
`153551355,
`55:
`WHEREAER 515551515155 535155151355
`A5sig55eg. and 5555353111612: 5555151511 151 555351551555 {515551 Asgigmr. 5111. 555113 5155155. 1:15.15: 555551 1155525555 155, 155
`and under 1218 95155551551; 5.5151
`
`WHEREAS. 5555555551511 551. and 11555155 1:115: 555111115. 551115155551551555 and 55555151555551.5551 5512 £116
`P5181512 11.5513115525551 5153556555155: (5115:1351 as 515’ Samanber 3, 2617 51.555 “ng $515555 Agreemmf’}.
`11:5 111511 1551515515551 5955551315515 and Assigaea. 55515131501" 51535115555: 5:.) 85511515551 555555. 5135115551 1551 15.515555311555151,
`515511555551; aaavaymw 511153. daiévgw £0 Assigme 55f 2111 151“ 115 right, 5115:: and 55115555151 1.55, m and
`151551515 11151 $555915; 511151 151. 551 1511111 511551155 51515 55511531555555 5535553531551 1115515531531, 111151 Amignw 5’55
`51515155115151 (1f 23155355511513: 35551 555555155515515555 35115152.
`
`51511155551551 59555151555115155. 1555 5155151155 55151
`NGW. TEiE‘REFORfi 1705 55535151 111551
`51155516153555}! 5)? which are 51555811331 askmwifidgmi, 1218 55555535 115551151,
`ifltemdifig {a 13:: §eg55i§y
`1555115551, 15515555535 agree 515 111111555551:
`
` A51 535‘ 5155: Effimfiw Date. Assigmr 115555515131 525111155355 11555153$.5515. 515555113555
`35111 513 5555555 55:5 555553515551. 55111 51525525311556:
`1551555115? 5565395555 5135 fi'fiifi A5555g51<555 511 cf
`Assignm5; 553555. 511151 155551
`5155551552555 555. 55: and 51111155 5113 5351mm, 5055515555“ 55115135 my
`5531953555155, 55555555555555. 51515355555515. 105155511155510515, 11515151151155555353315533555. 855565151151551. 111151
`5555535151515; 511" 5515121 51155155555155 P15535515 551535553131 555155518531 155151 11112555511 may 3:11: 555551555551 151555155155.
`The assignment 51555553531153.1551. 11.616511 155 1111:1515: £53 5112 1115 555135155113 55355531551111.1511 and 5155: 1:}:
`may 1115 555551151515.
`
`11
`
`124'
`
`11555515553555155555555 A2 may be 15555555511531. Assigmr 511511 5555151515. 1155;555555115551g5 ané
`(155155-55 such other 55555251155185.5555. (113685118313 351521 55355551155555 51151 $1551? 110 515611 53511165
`553155351 as 11153; be 55555555552553.1‘ 1555555255535 515553565 (:5 «11515551515: 55.5 (355553: out 15:3 91555551551035
`515551555 51115 A3555:5555555 515511 as 5551131 233 55155551551115: 5555555555531, 5115013515 95 51511115511515. 1:: 55-5055:
`mmgaiusiy 521315.10552515.
`9.0555515515555515:
`5511205525.
`3585555551
`155
`551355515551
`11551
`5515awakens
`mammpiateé 55535315}.
`
`55535155515115”; The 5151551355515 555551151ng 5551551151253 1555 53555555505 05“ P55155155 2155131 ’i"515(§<5115555155
`in 5125: 1551515551 States $155151: and Tmziemark {11515555 555 5650551 555555555555 a: 1558 55555155555:
`115151 (1551:5115 01‘" 11152 1155115555113 5351155555151 511551
`151
`53255155515 50 5555555555,
`11511:?
`155 51551555515655
`55512155555315, agents 3555355650555 115’ 555531 gm: 551 affix1512 15105515155155.5153 515555 52555555551555.12515515553 as
`151153: 1312: 5151155551512511 1331 this 5%113551555525: 15552155115555} 51111 51.05 15511115555 11) 125115513 55153! and 1111
`{5525555155 P15555515 51f 11151 {355111151 31111523 (:55 15111555511311s 55111555555511551555 P3555515
`
` 35:.
`59551511555553 51555111585115 11521111 11555 555315151111 512111
`25511
`1555515523 513 55515555555551
`5515511555515:y
`515 15151
`55555555515555
`15555551555555 51f any 51515551555515,
`51.555510551115151,
`51111151515153.5151.
`51111155151535,
`55111113511515.
`55.551351551155015,
`51555155551 or 51515155“
`51555554231.
`151551155515111'5511533 535 11111515 355551555555556515: 55.551555155553511 115 Assigme {$155115 1:15" 5155: 5555551555555,
`
`1 S
`
`RMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 3
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`imiufiing Assignm, a “Tribai ?arty“}, in each cam, in miatim {(3 any inter mamas
`swim: as‘ any oti‘m gmwmfimg in the (kiwi States Patam & ’2"mdammk {mice €112" may
`afiminisémfive gzmcmdmg that may he flier} fair the gamma m‘,’ invasiiaiatirgg m rmfigx'mg
`unsnfm‘cmblé an): Agsigfifii {’aimfis. For 9x33139533 a)? this Asssiwmt Agrmmem no
`pmfisism 9f this Asfiigmmm é‘tgmmmm aimiiifl 33s: imemmmd ii} musiimte s: waiwmf
`Amigmg’s at any W183" Trihai Page‘s; swam-Egg immunity as in any mm mamas mvécw
`m smfiiar gmcseéifiga
`
`:42
`
`Qgg‘ggfijfiggflggggg Assigmr am? Assigneg sac}; agkmxwia‘dgga and agree 5:11:32 aha
`mpresmmtfimls, warmmiess cawmmis, Qéligaiimm and mixer {semis mmaineé in the
`hang Fem} Agmmism‘ $32.33 mt 339: saspésrsesfimi Mash}: but m3; mania 31:} Mi farm
`mi? efiact tea the Sufi Mimi §mv§§§mi therein. “R; the extent that any pmviaim 3f 2M5
`agsignmem is izxmrssismxt m" mnfliafs with m Lang Ram: Agreemeag the: gkmviximas
`m? the Lang Farm Agmemzmt ma}: mmmi The partigs may (smegma 3mg fissigmnem
`in maitipie emazxngmrm my me of whicfiz nasad mi mama flu: sigfiaéum 51’ moms: than
`am: party, but a}: ami} cewtemwa taken togsther aha}: cisastiiute mm and the $5326
`imammam Any mumemam may he; fixemmsfi by fmsé‘miia 533‘ FR")? signatm‘a am such
`faaaimiifi at £38? Sigtmtmez ahail b3 damcfi 2m arigimi. Th2: tms and canéiiims {if
`this .ékgsignmem shafi be bindmg 31pm {be pamészs imam and may mspmfiw 333338352013?
`amfi assigms. Thig Assigmmm man be: gawmefii by and cmmimed in amsflama with
`the iziW§ 9f the State a? New Ym‘ii, wiflmut givifig effect to the yfis’migflefi Bf scnflifis
`0'5? Raw fimresuf.
`
`{Sigms‘mm Amway? Os”: 2% Fazbffmvmg Pay}
`
`3%}
`
`
`
`:A
`3 ~ 6'
`m
`m §~“
`K‘ fl‘x E‘I:\a$$(:r NT
`
`REELfiMMsi
`AME: 0425
`
`‘
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 4
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`EN W'E'FNESS ‘i’flEREDF, Assigms‘ mad Assigms haw: gamma}. {Emir mspfictiva duly
`anflmfizesfi efiicm’s :0 632231123 32113 Asaigmwm gs fifihfi Eflfifiii’vfi Bate.
`
`Sasha: Regis $1931:th Trim
`
`Name: Eric Thammm
`
`Name: A. Rama 323‘ 3631619
`
`Title: Tfibai Chief
`
`Titis: PmSidfim
`
`if?“ ”K.....
`
`s
`Nafim: Emmy Cam;
`
`f
`
`Tiiie: Tfi‘mi Chief
`
`
`
`Names: Micmsi Cemem
`
`Titie: E’n‘hai Chief
`
`Segmxgsre Fag? m Sokw-z Firm? Pawn? fissigtzzmm: aggregmefig ‘
`e}
`.%F .»
`x13
`
`‘ a *Pfi‘fE
`REEwmssz
`
` film/”‘7’
`
`AME: 0426
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 5
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`
`
`31.313333313331333
`
`1‘13»: 11231323313
`
`
`
`
`
`
`
`W...-W...T...........
`
`(3033331313Famgfrlflg 1
`.
`.
`
`
`1 33333333333 333333 39 13313333333 ‘
`.
`.
`
`
`.3...
`----3- .-...
`.--...
`'
`
`3333
`3
`5333.33 33333 3 333333333?31333333333333213333
`:33333333333
`
`
`
`
`
`
`3 a3333:33
`33333.333
`333333333333
`US
`1233.332333.
`E
`
`....i...
`....m_....________.::.....m.................. “W”
`
`333333333333
`3,323,131 __ 333333333313 33333333 335:3
`33$
`3
`
`
`
`
`
`133333.33-333:3
`3.333.333
`‘
`'
`33333-33113
`133333 333
`
`
`
`33321333313 33233:: 33.3 332333333233333
`
`
`
`31 F313281313
`13.3%“? 1158
`.
`33-33333232313
`
`
`
`
`
`
`3‘
`1.3?»Aug~2€313
`13i§fi1 8:3
`(313333333314
`
`9:238:31391
` .W".mflm.
`:31.333333333
`‘
`31333333333331.1116 3
`14332953713
`J
`
`
`~«
`E
`1.,33353
`A113 3313133331
`“313?:3331133213133
`
`
`
`
`
`
`
`.
`3333333333313
`.
`3:32.3332333
`33313211331031.3231
`
`21.133131313111831
`133333333333
`13
`
`13?Afig~21313
`...........Wé“WA-......“An—m“
`33333323333333.3333
`i BAEnBeanEG‘lBEEf
`11!§Q?,13'?33
`
`
`
`
`
`
`
`1 5.3"5311.3 20
`3
`13331313333;
`
`
`
`
`
`
`’30»33n~’31} .1 15
`_
`93113111103851
`3 15331 1 5”
`
`{11155133313733 31 33&333711131
`
`
`
`
`
`
`103812?35?" 3
`21.331333221304
`
`
`3
`1
`
`
`
`
`
`
`
`
`1 “333393.533":313333::31323
`33333333333333
`.
`
`133333.313.
`3
`3333331333333
`.
`3333333333333
`'
`‘
`
`
`
`
`
`11342313431
`.
`3131133123131'11‘3
`11.“1%1,§G§
`333.3”343.313-3115
`
`
`............MW‘s.
`“33.133313131111331
`.\
`3
`5
`1
`3
`
`...........;
`
`
` ‘3
`13333332313335
`
`......n...
`
`
`
`‘2? 1131,57533.
`
`
`1.13
`...3
` MW... ... .
`l
`m...m...........
`133;
`~
`333333333333;
`
`
`1
`33,333 3.35:3" 3.33
`
`
`3. MW:
`“3'33
`g
`g
`,3:3 “33 3333
`.
`.
`.
`.
`1
`33
`32333335333335.3333 .31 2‘33 $333233": Fem: 933133.333: (11.3513333333331332153333333333
`i3 .3-
`§
`«3
`‘ 3.33.3 A gm
`REE1i:0435 2 FRAME: 0427
`
`
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 6
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`mungMW
`
`
`
`”Em2211212221
`112121222
`111212221
`_
`...»...m......-....................--l
`
`
`2221221111 ‘
`‘
`2121211221111“
`
`
`:
`“"3"
`WW ............... . 'W"......................WSW.............................WWW
`
`
`1282111221122
`$211121N11,
`112111111113
`‘2
`1
`$122112i€11m1112212
`E Caus‘mv ' 1322211113112.
`
`
`
`
`
`
`
`
` “4...“...................................
`2222132215
`
`
`3331131253133
`
`“1.1233131“;12}2112
`22212111211111
`"
`11114111121
`'""111211W5112
`3841111228833
`
`
`321.3113335
`
`
`
`
`-
`2
`L 12111212222
`122112221113
`-
`
`
`
`22222222222222222
`~~u-~....
`
`
` E.‘‘‘‘‘‘‘‘‘‘- “EA—“mm““““““““““ \ ““*‘*‘*‘“:~“““““““““““ E }E11355"f'fl'j
`...—W.“
`“NW
`14121123813
`
`
`13f§5§3453.3
`21112111111211
`12111112212212
`
`32112111311122
`I1 44211122131 3
`......... m................ 2....
`..........m...E......_..............
`
`122112221113
`;
`WWW22
`
`
`‘
`.
`,1
`E
`22111111121122
`1
`‘ ““
`“‘1
`
`
`A W2.2151221221222“2222211224
`“.2
`
`PendmgE1211121113 1
`
`
`‘
`
`
`_‘ m
`
`2111112221111
`3
`—-,—-m--u-u«<-,““~“\\wi
`
`11221111211611
`
`1
`E
`
`
`
`“““““““““
`. 1
`
`
`
`
`
`
`
`""""1‘271‘1111222211
`
`3121411122136?
`
`...__2_....
`
`23312211011223
`
`E
`
`
`
` $131335”“.21 21341133936?
`
`315338.260 E'35}$120:291)?
`
`
`
`
`
`‘
`-
`,
`131355233339
`.
`2541112086
`321122126 91111211101131
`------------------------------------------------- WWW—«Wm W W
`
`fiajgwflgé
`E
`3?(32233136
`E
`312112912223 32911211111111
`
`12211112231
`12121222212
`1321111122
`.1
`‘
`E
`
`
`11122111117
`11112111211112
`21121111211211
`W2WWWWWW-fiWW_W..12+.
`“12......‘W
`mw -----1
`
`22212121311 13111112121111;
`1222111111112
`21111311122
`L.
`
`
`1122121121112
`1212212531
`'
`12.212WLEWWWWW.....“WW2WWLLWW
`
`
`REEL“:64353€3PRAME D428
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 7
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`l
`
`
`1
`Qm'nw’ (hwy-V111
`
`
`E3
`1
`!
`
`111111111; 11111
`M11111. 315W“! 111111111
`
`
`
`
`
`
`2311171111121 .
`
`
`
`
`811347331
`
`"R5115“V311
`1.11.111,31111111111111»:
`.1
`133115364
`
`3
`210131:21314
`33311111111:
`
`
`
`
`16.111111101112111"
`111~1111gu31113
`
`
`
`fihamianed
`iéfipwmm
`
`
`
`3
`1““
`
`“
`191132111151
`
`_ 1511:11:771.55....
`mem,
`
`
`““1
`Abandonad
`i
`111113114111
`
`:13Augfififl
`
`
`
`Aimwiomzi
`i24‘4”“ 13‘?
`§
`1111111361 1;
`1111111WW
`..
`...1.1i111111111_m_
`
`
`
`
`
`, 93
`=
`. 28Fabhifilé
`E3611§111gm
`—
`
`
`«11111111111111111111 1:; 3112111? Fawm 531231111: 21.331311111151111 figremaesm
`
`RECORDED: 09/08/2017
`
`
`
`'iPA gigT
`REEL: 0435
`FRAME0429
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`|PR2016-01 128
`
`SRMT 2103 - Pg. 8
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`